Top Markets
#1 bitcastle Token bitcastle Token +150.78%
#2 MowCat MowCat +86.94%
#3 MarsCoin MarsCoin +56.54%
#4 Palladium Network Palladium Network +53.08%
#5 Siren Siren +29.95%
#6 Bedrock Bedrock +24.07%
#7 Useless Coin Useless Coin +23.00%
#8 Pons Pons +20.02%
#9 ICON ICON +18.49%
#10 Asteroid Shiba Asteroid Shiba +15.57%
Coin of the day
bitcastle Token bitcastle Token
設定
言語
日本
通貨
USD
テーマ
VISEN Pharmaceuticals VISEN Pharmaceuticals

VISEN Pharmaceuticals

2561
株式のランク #16903
VISEN Pharmaceuticals operates as an investment holding company, concentrating... VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
株価
$2.47
時価総額
$269.21M
変化（1日）
-0.97%
変化（1年）
-57.18%
国
CN
取引 VISEN Pharmaceuticals (2561)

カテゴリー

Healthcare
VISEN Pharmaceuticals（2561）の株式分割履歴
VISEN Pharmaceuticals株（シンボル：2561）は合計で0回の株式分割を実施しました。
最新の株式分割はSep 03, 2026に行われました。
Sep 03, 2026より前に購入された2561株は、現在02561株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率 国
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 0 -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 0 -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 0 -
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 5 x119
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 0 -
CH